Remote video URL
10-minute watch
| Talk 15
of 15
ASCO, EHA & ICML: Expert perspective
Brexucabtagene autoleucel in R/R B‑cell acute lymphoblastic leukaemia: Real‑world data
Dr Bijal Shah
Moffitt Cancer Center, Tampa, FL, USA
Dr Bijal Shah, from the Moffitt Cancer Center, Florida, USA, summarises real-world outcomes with brexucabtagene autoleucel in acute lymphoblastic leukaemia, released during the 2023 summer congress season
Read more
Talks in this series
Interested in this topic?
×
We value your feedback to help us improve and inform future materials
Please select a star rating out of 5 stat best describes your experience of this content
(1 = low; 5 = high)